$12.79 -0.53 (-3.98%)
12/3/2009 4:00 PM

Cepheid (CPHD)

CAPS Rating: 4 out of 5

A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.

Featured Broker Partners